Join Us

David Mankoff, M.D., Ph.D.

Save as Favorite
Sign in to receive recommendations (Learn more)
Mankoff david thumb tcm8 332535

David Mankoff, M.D., Ph.D. is professor of radiology in the division of nuclear medicine at the University of Washington and holds adjunct appointments in medicine (endocrinology) and bioengineering. Dr. Mankoff is board-certified in nuclear medicine and holds a Ph.D. in bioengineering with a focus on PET instrumentation. He practices nuclear medicine at the Seattle Cancer Care Alliance, University of Washington Medical Center, and affiliated centers, with a special interest in oncologic and endocrine applications of nuclear medicine and treatment of endocrine tumors. Dr. Mankoff's research focuses on molecular imaging of cancer, especially breast cancer, and emphasizes therapeutic monitoring and identifying factors mediating resistance. Dr. Mankoff is on the Board of Directors for the American Board of Nuclear Medicine and chairs the Experimental Imaging Sciences Committee of the American College of Radiology Imaging Network (ACRIN). He is also on the editorial boards of Nuclear Medicine and Biology, Breast Cancer Research, Journal of Nuclear Medicine, Clinical Cancer Research, Journal of Clinical Oncology, and Molecular Imaging and Biology. He served on the NIH Cancer Biomarkers Study Section and the Society of Nuclear Medicine Molecular Imaging Center of Excellence.

Dr. Mankoff says, "I am honored to have the chance to serve on the Professional Advisory Board for Breastcancer.org. Breastcancer.org provides an outstanding and very valuable resource for breast cancer patients and families by providing them with an up-to-date, comprehensive, and accessible source of information on breast cancer science, treatment, and survivorship. It is a pleasure to work with Breastcancer.org and help to support its important work."


Was this article helpful? Yes / No
Rn icon

Can we help guide you?

Create a profile for better recommendations


  • Breast Cancer Stages

    The stage of a breast cancer is determined by the cancer’s characteristics, such as how large it...

  • HER2 Status

    HER2 (human epidermal growth factor receptor 2) is a gene that can play a role in the development...

  • Ductal Carcinoma In Situ (DCIS)

    Ductal carcinoma in situ (DCIS) is non-invasive breast cancer. Ductal means that the cancer...


Beta How does this work? Learn more

Covid19 sidebar v04.4
Back to Top